Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]

View source ↗

Summary

Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myeloma, and chronic lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• SCH 727965

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors, Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED